Fichtl Marek

Novel disease-causing variants and phenotypic features of X-linked megalocornea.

The study expands the spectrum of pathogenic variants and the ocular and brain abnormalities that have been identified in individuals with MGC1.

MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension.

Once-daily NET/LAT was non-inferior to BIM/TIM in IOP reduction in OAG and OHT, with AEs consistent with previous findings. NET/LAT offers a compelling alternative FDC treatment option for OAG and OHT.